Wearable Devices Empowering Active Health Initiatives for High-Risk Stroke Populations
AISP
1 other identifier
interventional
300
1 country
1
Brief Summary
The purpose of this study is to evaluate the control effect of smart wearable devices on key risk factors in the high-risk populations for stroke
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable hypertension
Started Apr 2025
Shorter than P25 for not_applicable hypertension
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
March 30, 2025
CompletedFirst Posted
Study publicly available on registry
April 20, 2025
CompletedStudy Start
First participant enrolled
April 20, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 20, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
April 20, 2026
CompletedApril 30, 2025
March 1, 2025
6 months
March 30, 2025
April 27, 2025
Conditions
Outcome Measures
Primary Outcomes (1)
medication adherence and risk factor control rates
1.The medication rates and control rates for hypertension; 2.The medication rates and control rates for hyperglycemia; 3. The medication rates and control rates for hyperlipidemia; 4.The medication rates and control rates for obesity.
6 months
Secondary Outcomes (1)
incident vascular events, including stroke, coronary heart disease (CHD), peripheral vascular disease (PVD), and other related cardiovascular events
6 months
Study Arms (2)
With Wearable Devices
EXPERIMENTALParticipants utilize wearable devices (smart wristbands) 24 hours a day for 6 months and receive medication reminders for each use and heart rate monitoring.
Without Wearable Devices
NO INTERVENTIONParticipants do not utilize wearable devices (smart wristbands) .
Interventions
Participants utilize wearable devices (smart wristbands) 24 hours a day for 6 months. Wearable devices can provide medication reminders for each use and heart rate monitoring.
Eligibility Criteria
You may qualify if:
- Diagnosed with hypertension;
- Diagnosed with diabetes;
- Diagnosed with atrial fibrillation;
- Smoking subjects;
- Physical inactive subjects;
- Obesity and overweight subjects;
- Must be able to use smart wearable devices.
You may not qualify if:
- Diagnosed with malignancies;
- Diagnosed with psychiatric disorders;
- Diagnosed with cognitive impairment;
- Unable to operate smart wearable devices.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Affiliated Hospital of Nantong University
Nantong, Jiangsu, 226000, China
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- STUDY CHAIR
Qiuhong Ji, MD, PhD
Affiliated Hospital of Nantong University
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
March 30, 2025
First Posted
April 20, 2025
Study Start
April 20, 2025
Primary Completion
October 20, 2025
Study Completion
April 20, 2026
Last Updated
April 30, 2025
Record last verified: 2025-03
Data Sharing
- IPD Sharing
- Will not share